These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 36039734
1. Tanshinone IIA reduces pyroptosis in rats with coronary microembolization by inhibiting the TLR4/MyD88/NF-κB/NLRP3 pathway. Li HL, Li T, Chen ZQ, Li L. Korean J Physiol Pharmacol; 2022 Sep 01; 26(5):335-345. PubMed ID: 36039734 [Abstract] [Full Text] [Related]
3. Effects of the TLR4/Myd88/NF-κB Signaling Pathway on NLRP3 Inflammasome in Coronary Microembolization-Induced Myocardial Injury. Su Q, Li L, Sun Y, Yang H, Ye Z, Zhao J. Cell Physiol Biochem; 2018 Sep 01; 47(4):1497-1508. PubMed ID: 29940584 [Abstract] [Full Text] [Related]
4. Tanshinone IIA inhibits cardiomyocyte pyroptosis through TLR4/NF-κB p65 pathway after acute myocardial infarction. Chai R, Ye Z, Xue W, Shi S, Wei Y, Hu Y, Wu H. Front Cell Dev Biol; 2023 Sep 01; 11():1252942. PubMed ID: 37766966 [Abstract] [Full Text] [Related]
5. Nicorandil inhibits TLR4/MyD88/NF-κB/NLRP3 signaling pathway to reduce pyroptosis in rats with myocardial infarction. Chen F, Chen ZQ, Zhong GL, Zhu JJ. Exp Biol Med (Maywood); 2021 Sep 01; 246(17):1938-1947. PubMed ID: 34034564 [Abstract] [Full Text] [Related]
8. Colchicine ameliorates myocardial injury induced by coronary microembolization through suppressing pyroptosis via the AMPK/SIRT1/NLRP3 signaling pathway. Li H, Yang H, Qin Z, Wang Q, Li L. BMC Cardiovasc Disord; 2024 Jan 03; 24(1):23. PubMed ID: 38172692 [Abstract] [Full Text] [Related]
9. Protective effects and mechanism of curcumin on myocardial injury induced by coronary microembolization. Liu Y, Liu Y, Huang X, Zhang J, Yang L. J Cell Biochem; 2019 Apr 03; 120(4):5695-5703. PubMed ID: 30324684 [Abstract] [Full Text] [Related]
10. Atorvastatin reduces contrast media-induced pyroptosis of renal tubular epithelial cells by inhibiting the TLR4/MyD88/NF-κB signaling pathway. Yue RZ, Li YJ, Su BH, Li CJ, Zeng R. BMC Nephrol; 2023 Feb 02; 24(1):25. PubMed ID: 36732683 [Abstract] [Full Text] [Related]
11. Mechanism for effect of tanshinone IIA on alleviating cardiomyocyte injury induced by oxygen glucose deprivation. Xu Q, Wang Z, You S, Yuan L, Li H. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar 28; 48(3):369-375. PubMed ID: 37164920 [Abstract] [Full Text] [Related]
12. Long non-coding RNA Sox2OT promotes coronary microembolization-induced myocardial injury by mediating pyroptosis. Xuan L, Fu D, Zhen D, Bai D, Yu L, Gong G. ESC Heart Fail; 2022 Jun 28; 9(3):1689-1702. PubMed ID: 35304834 [Abstract] [Full Text] [Related]
13. Hypoxia-inducible factor-1α attenuates myocardial inflammatory injury in rats induced by coronary microembolization. Chen QF, Wang W, Huang Z, Huang DL. An Acad Bras Cienc; 2020 Jun 28; 92(1):e20190658. PubMed ID: 32428089 [Abstract] [Full Text] [Related]
14. Tanshinone IIA prevents left ventricular remodelling via the TLR4/MyD88/NF-κB signalling pathway in rats with myocardial infarction. Wu DM, Wang YJ, Han XR, Wen X, Li L, Xu L, Lu J, Zheng YL. J Cell Mol Med; 2018 Jun 28; 22(6):3058-3072. PubMed ID: 29524303 [Abstract] [Full Text] [Related]
15. LuQi Formula Ameliorates Myocardial Fibrosis by Suppressing TLR4/MyD88/NF-κB Pathway and NLRP3 Inflammasome Activation in Mice with Myocardial Infarction. Zhang X, Qu H, Yang T, Liu Q, Zhao D, Liu W, Wang T, Zhou H. Evid Based Complement Alternat Med; 2022 Jun 28; 2022():5867987. PubMed ID: 35310035 [Abstract] [Full Text] [Related]
16. Tanshinone IIA protects intestinal epithelial cells from deoxynivalenol-induced pyroptosis. Zhang C, Chen F, Wang Y, Zhang K, Yang X, Wang X. Ecotoxicol Environ Saf; 2024 Jan 01; 269():115743. PubMed ID: 38035519 [Abstract] [Full Text] [Related]
17. Role of high mobility group A1/nuclear factor-kappa B signaling in coronary microembolization-induced myocardial injury. Su Q, Lv X, Sun Y, Yang H, Ye Z, Li L. Biomed Pharmacother; 2018 Sep 01; 105():1164-1171. PubMed ID: 30021353 [Abstract] [Full Text] [Related]
18. Tanshinone IIA Exerts Anti-Inflammatory and Immune-Regulating Effects on Vulnerable Atherosclerotic Plaque Partially via the TLR4/MyD88/NF-κB Signal Pathway. Chen Z, Gao X, Jiao Y, Qiu Y, Wang A, Yu M, Che F, Li S, Liu J, Li J, Zhang H, Yu C, Li G, Gao Y, Pan L, Sun W, Guo J, Cao B, Zhu Y, Xu H. Front Pharmacol; 2019 Sep 01; 10():850. PubMed ID: 31402870 [Abstract] [Full Text] [Related]
19. Tanshinone IIA mediates protection from diabetes kidney disease by inhibiting oxidative stress induced pyroptosis. Wu Q, Guan YB, Zhang KJ, Li L, Zhou Y. J Ethnopharmacol; 2023 Nov 15; 316():116667. PubMed ID: 37257702 [Abstract] [Full Text] [Related]
20. Octreotide and melatonin alleviate inflammasome-induced pyroptosis through inhibition of TLR4-NF-κB-NLRP3 pathway in hepatic ischemia/reperfusion injury. El-Sisi AEE, Sokar SS, Shebl AM, Mohamed DZ, Abu-Risha SE. Toxicol Appl Pharmacol; 2021 Jan 01; 410():115340. PubMed ID: 33264646 [Abstract] [Full Text] [Related] Page: [Next] [New Search]